Arix Bioscience is a global healthcare and life science company that drives value in private and public companies through operational and strategic direction as well as patient capital.
Led by renowned figures in the healthcare and life science sectors, Arix Bioscience is headquartered in London and has an office in New York.
Our extensive experience in academic science, clinical and commercial strategy, company operations, mergers and acquisitions, venture capital and corporate finance puts us in an especially strong position to build and support a wide range of businesses and technologies.
Arix Bioscience has privileged agreements with leading universities in the UK, Europe and Australia, providing direct access to innovative new technologies. We also have access to a broad range of research projects from US academic institutions.